These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2206933)

  • 1. Knowledge of colorectal cancer and use of screening tests among higher-risk persons.
    Polednak AP
    J Cancer Educ; 1990; 5(2):115-24. PubMed ID: 2206933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of family history of cancer and environmental factors to the risk of colorectal cancer: a case-control study.
    Kotake K; Koyama Y; Nasu J; Fukutomi T; Yamaguchi N
    Jpn J Clin Oncol; 1995 Oct; 25(5):195-202. PubMed ID: 7474407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer by primary-care physicians in Long Island (New York) and Connecticut.
    Polednak AP
    Cancer Detect Prev; 1989; 13(5-6):301-9. PubMed ID: 2743351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tea consumption and risk of cancer of the colon and rectum.
    Cerhan JR; Putnam SD; Bianchi GD; Parker AS; Lynch CF; Cantor KP
    Nutr Cancer; 2001; 41(1-2):33-40. PubMed ID: 12094626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of colorectal cancer and use of screening tests in persons 40-74 years of age.
    Polednak AP
    Prev Med; 1990 Mar; 19(2):213-26. PubMed ID: 2359743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer.
    Diehl AK
    J Fam Pract; 1981 Apr; 12(4):625-32. PubMed ID: 7205165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
    Loss J; Eichhorn C; Nagel E
    Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey.
    Thorpe LE; Mostashari F; Hajat A; Nash D; Karpati A; Weber T; Winawer S; Neugut AI; Awad A; Zevallos M; Remy P; Frieden T;
    Cancer; 2005 Sep; 104(5):1075-82. PubMed ID: 16044401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
    Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
    Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.